Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

Clinical trial NCT07549698 · RECRUITING

Trial details

NCT number: NCT07549698
Sponsor: CRISPR Therapeutics AG
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Warm Autoimmune Hemolytic Anemia (WAIHA)ITP - Immune Thrombocytopenia Warm Autoimmune Hemolytic Anemia Immune Thrombocytopenic Purpura

Start date: 2026-06-01
Primary completion: 2033-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.